<div id="readability-page-1"><p>Hood River Capital Management LLC raised its holdings in  Guardant Health, Inc. (NASDAQ:GH - Free Report) by 4.1% in the 2nd quarter, according to the company in its most recent filing with the SEC. The firm owned 245,701 shares of the company's stock after acquiring an additional 9,637 shares during the quarter. Hood River Capital Management LLC owned approximately 0.20% of Guardant Health worth $12,786,000 as of its most recent SEC filing.</p><div><p><span></span><span>Get <strong>Guardant Health</strong> alerts:</span></p></div><ul><li>4 Healthcare Stocks With Massive Gains—and More to Come</li></ul><p>A number of other hedge funds also recently modified their holdings of GH. IFP Advisors Inc grew its stake in shares of  Guardant Health by 120.1% in the second quarter. IFP Advisors Inc now owns 612 shares of the company's stock worth $33,000 after purchasing an additional 334 shares during the last quarter.  Signaturefd LLC grew its position in shares of  Guardant Health by 50.5% in the 2nd quarter. Signaturefd LLC now owns 635 shares of the company's stock valued at $33,000 after buying an additional 213 shares during the last quarter.  Allworth Financial LP grew its position in shares of  Guardant Health by 358.4% in the 2nd quarter. Allworth Financial LP now owns 706 shares of the company's stock valued at $37,000 after buying an additional 552 shares during the last quarter.  FNY Investment Advisers LLC acquired a new stake in shares of  Guardant Health in the second quarter valued at about $62,000.  Finally, SVB Wealth LLC bought a new position in shares of  Guardant Health during the first quarter worth about $54,000. Institutional investors and hedge funds own  92.60% of the company's stock. </p><h2>Guardant Health Stock Up 2.1%</h2><p>Shares of NASDAQ GH opened at $104.17 on Tuesday. The firm has a market cap of $13.13 billion, a PE ratio of -32.45 and a beta of 1.58. Guardant Health, Inc. has a 12-month low of $29.91 and a 12-month high of $112.43. The company's fifty day simple moving average is $85.51 and its 200 day simple moving average is $63.90. </p><ul><li>Deciphering Disruption: Inside Cathie Wood's Latest Plays</li></ul><p>Guardant Health (NASDAQ:GH - Get Free Report) last announced its quarterly earnings data on Wednesday, October 29th. The company reported ($0.39) earnings per share for the quarter, beating the consensus estimate of ($0.48) by $0.09. Guardant Health's quarterly revenue was up 38.5% on a year-over-year basis. During the same quarter last year, the business posted ($0.88) EPS.  On average, equities analysts predict that  Guardant Health, Inc. will post -2.9 earnings per share for the current year. </p><h2>Insider Buying and Selling at Guardant Health</h2><p>In other news, CFO Michael Brian Bell sold 80,362 shares of the company's stock in a transaction that occurred on Friday, December 5th. The stock was sold at an average price of $103.14, for a total transaction of $8,288,536.68. Following the transaction, the chief financial officer directly owned 28,052 shares of the company's stock, valued at $2,893,283.28. This represents a 74.13% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available through this link. Also, insider Chris Freeman sold 31,452 shares of the stock in a transaction on Friday, December 5th. The stock was sold at an average price of $103.07, for a total value of $3,241,757.64. Following the completion of the transaction, the insider owned 25,987 shares in the company, valued at approximately $2,678,480.09. This represents a 54.76% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 208,653 shares of company stock worth $21,597,632 in the last quarter. Company insiders own  6.10% of the company's stock. </p><h2>Analyst Ratings Changes</h2><ul><li>3 Fast-Growing Stocks Analysts See Doubling in Price</li></ul><p>Several brokerages recently commented on GH. TD Cowen upped their target price on Guardant Health from $63.00 to $72.00 and gave the company a &#34;buy&#34; rating in a report on Thursday, September 25th. Leerink Partners upped their price objective on shares of Guardant Health from $70.00 to $75.00 and gave the company an &#34;outperform&#34; rating in a research note on Thursday, September 25th. Canaccord Genuity Group  set a $100.00 price objective on shares of Guardant Health in a research report on Thursday, October 30th. Citigroup boosted their target price on shares of Guardant Health from $65.00 to $100.00 and gave the company a &#34;buy&#34; rating in a report on Thursday, October 30th. Finally, Guggenheim increased their price target on Guardant Health from $56.00 to $67.00 and gave the stock a &#34;buy&#34; rating in a report on Thursday, September 25th. Twenty-three research analysts have rated the stock with a Buy rating and one  has given a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $80.86.</p><p><b>Get Our Latest Report on Guardant Health</b></p><h2>Guardant Health Company Profile</h2> (Free Report)<p>Guardant Health, Inc, a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers.</p><h2>See Also</h2><ul><li>Five stocks we like better than Guardant Health</li><li>Consumer Discretionary Stocks Explained</li><li>Top 5 Highest-Rated Dividend Stocks, According to MarketBeat</li><li>Investing In Automotive Stocks</li><li>What Dollar Tree’s Surge and Home Depot’s Slide Say About Consumer Health</li><li>CD Calculator: Certificate of Deposit Calculator </li><li>3 Stocks Most Likely to Split in 2026</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9R0g?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9R0g"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Guardant Health Right Now?</h2><p>Before you consider Guardant Health, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Guardant Health wasn't on the list.</p><p>While Guardant Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Hood River Capital Management LLC increased its stake in Guardant Health, Inc. by 4.1% in Q2, owning 245,701 shares worth $12.79 million. Analysts have raised target prices for Guardant Health, with several brokerages giving a 'buy' rating. Insiders sold significant shares recently, and institutional investors own 92.60% of the stock. Guardant Health's stock opened at $104.17, with a market cap of $13.13 billion.</p>

Hood River Capital Management LLC Has $12.79 Million Stock Holdings in Guardant Health, Inc. $GH